The excitement around generative AI has only grown over the past few years thanks to the sustained popularity of products like ChatGPT and Midjourney.
As a matter of good business, medical marketers have experimented with these tools and — to varying degrees — incorporated them into their workflows.
However, many are wondering what the next act will look like for AI in the industry and how this innovative tech could produce more practical results going forward.
According to a recent piece in MM+M , 72% of patients expect personalized communications from healthcare companies. The industry sees this being a significant focus in 2025.
At EVERSANA, our experts agree that technology like GenAI will revolutionize the patient journey. Our Chief Digital Officer, Scott Snyder, recently shared his insights with MM+M. Read more here (LINK).
“In 2025, expect AI, fueled by new GenAI-enabled capabilities, to chip away at gains in efficiency, accuracy, and speed across the entire pharma marketing value chain including content creation, review, and dissemination, and personalization.” — Scott Snyder, chief digital officer at Eversana.
Read more of this article from MM+M.
Connect With An Expert!
Author
Scott serves as EVERSANA’s Chief Digital Officer, driving digital transformation for employees, clients, and the patients we serve. He brings more than 30 years of experience in emerging technologies and digital transformation across both…